RxDoctor Payments Data

Mohammed Elzeneini

Interventional Cardiology · Mobile, ALNPI 1518452663

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (36.7%), food and beverage and grants — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Medtronic at 40.8% of the total.

$22,550in general payments, 2019–2025

Across 127 payments — averaging $177.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$9K
  • Abbott$4K
  • Penumbra, Inc.$2K
  • Edwards Lifesciences$2K
  • Boston Scientific$2K
  • Philips North America LLC$960
  • plus $3K from 13 others

What the payments were for

  • Grants$7,06331%
  • Travel & lodging$8,28337%
  • Food & beverage$7,20232%
  • Education$10%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,550 in reported general payments places this provider in the 75th percentile of 109 interventional cardiology providers in Alabama.

See all interventional cardiology providers in Alabama

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate19$155
Atorvastatin Calcium15$89

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Mobile

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →